Clinical Trial Update: Osteocel® Plus in Posterior Lumbar Interbody Fusion (PLIF)

View source ↗

Summary

This document reports a completed clinical trial evaluating Osteocel Plus in posterior lumbar interbody fusion for degenerative disc disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease

Drugs mentioned

• Osteocel Plus

Snippet

Sponsor: NuVasive | Conditions: Degenerative Disc Disease | Status: COMPLETED